Comorbidities in patients hospitalized due to chronic obstructive pulmonary disease. A comparative analysis of the ECCO and ESMI studies;Comorbilidades en pacientes hospitalizados por enfermedad pulmonar obstructiva crónica. Análisis comparativo de los estudios ECCO y ESMI

Revista Clinica Espanola

Volumn 212, Issue 6, 2012, Pages 281-286

  Almagro, P ^a   Lopez F ^b   Cabrera, F J ^c   Portillo, J ^d   Fernandez Ruiz M ^e   Zubillaga, E ^f   Diez J ^g   Roman P ^h   Murcia Zaragoza, J ^b   Boixeda, R ⁱ   Murio, C ^j   Soriano, J B ^k  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

^b HOSPITAL VEGA BAJA   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE CIUDAD REAL   (Spain)

^e Instituto de Investigación 12 de Octubre ^*  (Spain)

^f HOSPITAL DONOSTIA   (Spain)

^g Hospital Royo Vilanova   (Spain)

^h HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

ⁱ HOSPITAL DE MATARÓ   (Spain)

^j Laboratorios Chiesi   (Spain)

^k Fundacion Caubet CIMERA   (Spain)

more..

Author keywords

Chronic obstructive pulmonary disease; Comorbidities; Hospitalization

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE EXACERBATION; FEMALE; HEART FAILURE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERIPHERAL VASCULAR DISEASE; PREVALENCE; QUESTIONNAIRE; REVIEW;

EID: 84861714183     PISSN: 00142565     EISSN: 15781860     Source Type: Journal    
DOI: 10.1016/j.rce.2012.02.014     Document Type: Article

References (30)

1. A.T. López, K. Shibuya, C. Rao, C.D. Mathers, A.L. Hansel, and L.S. Held Chronic obstructive pulmonary disease: current burden and future projections Eur Respir J 27 2006 397 412 (Pubitemid 43180921)
2. M. Miravitlles, J.B. Soriano, F. García-Río, L. Muñoz, E. Duran-Tauleria, and G. Sánchez Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities Thorax 64 2009 863 868
3. Instituto Nacional de Estadística [consultado 7 Oct 2011]. Disponible en: http://www.inebase.es
4. P.J. Barnes, and B.R. Celli Systemic manifestations and comorbidities of COPD Eur Respir J 33 2009 1165 1185
5. J.B. Soriano, G.T. Visick, H. Muellerova, N. Payvandi, and A.L. Hansell Patterns of comorbidities in newly diagnosed COPD and asthma in primary care Chest 128 2005 2099 2107 (Pubitemid 41507547)
6. P. Almagro, F. López García, F.J. Cabrera, L. Montero, D. Morchón, and J. Díez Study of the comorbidities in hospitalized patients due to decompensated chronic obstructive pulmonary disease attended in the Internal Medicine Services. ECCO study Rev Clin Esp 210 2010 101 108
7. J. García-Aymerich, F.P. Gómez, M. Benet, E. Farrero, X. Basagaña, and A. Gayete Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes Thorax 66 2011 430 437
8. L.M. Fabbri, and K.F. Rabe From COPD to chronic systemic inflammatory syndrome Lancet 370 2007 797 799 (Pubitemid 47320803)
9. L.M. Fabbri, F. Luppi, B. Beghé, and K.F. Rabe Complex chronic comorbidities of COPD Eur Respir J 31 2008 204 212
10. P. Almagro, E. Calbo, A. Ochoa de Echagüen, B. Barreiro, S. Quintana, and J.L. Heredia Mortality after hospitalization for COPD Chest 121 2002 1441 1448 (Pubitemid 34499653)
11. C. Schneider, U. Bothner, S.S. Jick, and C.R. Meier Chronic obstructive pulmonary disease and the risk of cardiovascular diseases Eur J Epidemiol 25 2010 253 260
12. J.P. de Torres, J.M. Marín, C. Casanova, C. Cote, S. Carrizo, and E. Córdoba-Lanus Lung Cancer in patients with COPD: incidence and predicting factors Am J Respir Crit Care 184 2011 913 919
13. P.M. Calverley, J.A. Anderson, B. Celli, G.T. Ferguson, C. Jenkins, and P.W. Jones Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N Engl J Med 356 2007 775 789 (Pubitemid 46294610)
14. F. Pozo-Rodríguez, C.J. Álvarez, A. Castro-Acosta, C. Melero Moreno, A. Capelastegui, and C. Esteban Clinical audit of patients admitted to hospital in Spain due to exacerbation of COPD (AUDIPOC study): method and organisation Arch Bronconeumol 46 2010 349 357
15. C. San Román Terán, R. Guijarro Merino, R. Gómez Huelgas, L. Montero Ribas Grupo de trabajo de EPOC de la Sociedad Española de Medicina Interna Epidemiología hospitalaria de la EPOC en España Rev Clin Esp 207 Suppl 1 2007 S3 S7
16. N.R. Anthonisen, J. Manfreda, C.P. Warren, E.S. Hershfield, G.K. Harding, and N.A. Nelson Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease Ann Intern Med 106 1987 196 204 (Pubitemid 17009877)
17. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383 (Pubitemid 17055592)
18. P. Almagro, M. Salvadó, C. García-Vidal, M. Rodríguez-Carballeira, M. Delgado, and B. Barreiro Recent improvement in long-term survival after a COPD hospitalisation Thorax 65 2010 298 302
19. T.L. Hackett, D. Stefanowicz, F. Aminuddin, D.D. Sin, J.E. Connett, and N.R. Anthonisen Effect of gene environment interactions on lung function and cardiovascular disease in COPD Int J Chron Obstruct Pulmon Dis 6 2011 277 287
20. D.D. Sin, and S.F. Man Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases. The potential role of systemic inflammation in chronic obstructive pulmonary disease Circulation 107 2003 1514 1519 (Pubitemid 36378490)
21. J. Finkelstein, E. Cha, and S.M. Scharf Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity Int J Chron Obstruct Pulmon Dis 4 2009 337 349
22. J.R. Feary, L.C. Rodrigues, C.J. Smith, R.B. Hubbard, J.E. Gibson, and R. Johanna Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care Thorax 65 2010 956 962
23. A.A. Dalal, M. Shah, O. Lunacsek, and N.A. Hanania Clinical and economic burden of patients diagnosed with COPD with comorbid cardiovascular disease Respir Med 105 2011 1516 1522
24. J. Zhang, F.H. Rutten, M.J. Cramer, J.W. Lammers, N.P. Zuithoff, and A.W. Hoes The importance of cardiovascular disease for mortality in patients with COPD: a prognostic cohort study Fam Pract 28 2011 474 481
25. J.B. Soriano Ortiz, P. Almagro, and J.S. Roig Causes of mortality in COPD Arch Bronconeumol 45 Suppl 4 2009 S8 S13
26. M.L. Render, A.S. Weinstein, and A.S. Blaustein Left ventricular dysfunction in deteriorating patients with chronic obstructive pulmonary disease Chest 107 1995 162 168
27. L.A. Rodríguez, M.A. Wallander, E. Martín-Merino, and S. Johansson Heart failure, myocardial infarction, lung cancer and death in COPD patients: a UK primary care study Respir Med 104 2010 1691 1699
28. J. Recio-Iglesias, J. Grau-Amorós, F. Formiga, M. Camafort-Babkowski, J.C. Trullàs-Vila, and A. Rodríguez Chronic obstructive pulmonary disease on in patients with heart failure. GESAIC study results Med Clin (Barc) 134 2010 427 432
29. M. Montero Pérez-Barquero, P. Conthe Gutiérrez, P. Román Sánchez, J. García Alegría, J. Forteza-Rey Grupo de Trabajo de Insuficiencia Cardiaca de Sociedad Española de Medicina Interna (estudio SEMI-IC) Morbidity from patients admitted for heart failure in the departments of internal medicine Rev Clin Esp 210 2010 149 158
30. J. Díez-Manglano, F. López-García, J. Barquero-Romero, N. Galofré-Álvaro, L. Montero-Rivas, and P. Almagro-Mena Risk of osteoporotic fracture and hip fracture in patients with chronic obstructive pulmonary disease Rev Clin Esp 211 2011 443 449